News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Helene Depui Ekdal new Clinical Development Director

February 11, 2019

Helene Depui Ekdal started as a new Clinical Development Director in the end of January.

Helene has a very extensive experience of drug development from 25 years at AstraZeneca, primarily through roles with responsibility for clinical studies and its parts – planning, execution, read out and reporting. Helene most recently comes from a role as Senior Director, Global Value Chain Leader within Global Operational Excellence, AstraZeneca.

Helene has during her time at AstraZeneca been responsible for and led a large number of global clinical studies and programs with extensive cross-functional organizations in late development phase, which has led to products being registered on the market e.g. BRILINTA®.

Helene holds a Master of Science in Chemistry, Chalmers University of Technology and an MBA, Gothenburg School of Economics.



Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10